clinical-trial is the sole category represented across all 1 tracked stories. UTHealth Houston is most often covered alongside Casey Crump, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. UTHealth Houston appears in 1 tracked Biotech story from July 21, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about UTHealth Houston
clinical-trial is the sole category represented across all 1 tracked stories. UTHealth Houston is most often covered alongside Casey Crump, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. UTHealth Houston appears in 1 tracked Biotech story from July 21, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering UTHealth Houston. Shared-story counts are live from our verified record — not editorial picks.
A PLOS Medicine study reveals that gestational diabetes drives a 3.8-fold higher long-term risk of peripheral artery disease, with other pregnancy complications also significant. For biotech and pharma, this uncovers a defined, decades-long at-risk population for vascular disease therapies and biomarker development.